Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-molecular-weight heparin for prevention of placental insufficiency complications in high-risk pregnant women without thrombophilia
2010-023597-39Phase 3Completed
- Sponsor
- LluÃs Cabero Roura
- Start
- Jan 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of enoxaparin in placental insufficiency, preeclampsia and intrauterine growth restriction (IUGR) (2 arms), sponsored by LluÃs Cabero Roura. Primary endpoint: Development of preeclampsia. Started Jan 2011; status: completed.
02
Drugs
enoxaparin
03
Conditions
placental insufficiencypreeclampsiaintrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on 2010-023597-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023597-39.